Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Repurposing dimethyl fumarate as an antiepileptogenic and disease-modifying treatment for drug-resistant epilepsy

Fig. 3

DMF prevents neuronal cell loss in the hippocampus following SE. A Representative images of the hippocampi of rats subjected to KA-SE and treated with vehicle (n = 6, left) or DMF (200 mg/kg/day over 7 days, n = 6, right). CA1 and CA3 (highlighted in yellow) regions were analyzed for neuronal density 1 week following KA-SE onset. Scale bar = 500 Âµm. B, D Representative images (zoom view) of the CA1 region (B) and CA3 (D) of animals, as in (A), illustrating the staining of neurons (NeuN, green). The nuclei were stained with DAPI (blue). Scale bars = 50 ÎĽm. C, E Quantification of the number of NeuN cells per 1 mm2 of tissue in CA1 (C) and CA3 (E). Data are expressed as the mean ± SEM. **P < 0.01 and ***P < 0.001 after one-way ANOVA followed by Tukey’s post hoc test

Back to article page